Page last updated: 2024-08-24

telmisartan and l 158809

telmisartan has been researched along with l 158809 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berellini, G; Cruciani, G; Mannhold, R1
Giridhar, R; Murumkar, P; Naik, P; Yadav, MR1
Bigge, CF; Casimiro-Garcia, A; Chen, J; Davis, JA; Dudley, DA; Edmunds, JJ; Ellis, T; Esmaeil, N; Filzen, GF; Flynn, D; Geyer, A; Heemstra, RJ; Jalaie, M; Ohren, JF; Ostroski, R; Schaum, RP; Stoner, C1
Bauer, JH; Reams, GP1

Reviews

2 review(s) available for telmisartan and l 158809

ArticleYear
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.
    Bioorganic & medicinal chemistry, 2010, Dec-15, Volume: 18, Issue:24

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Losartan

2010
The angiotensin II type 1 receptor antagonists. A new class of antihypertensive drugs.
    Archives of internal medicine, 1995, Jul-10, Volume: 155, Issue:13

    Topics: Acrylates; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Humans; Imidazoles; Irbesartan; Losartan; Pyridines; Quinolines; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan

1995

Other Studies

2 other study(ies) available for telmisartan and l 158809

ArticleYear
Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists.
    Journal of medicinal chemistry, 2005, Jun-30, Volume: 48, Issue:13

    Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Binding Sites; Biphenyl Compounds; Kinetics; Losartan; Models, Molecular; Molecular Conformation; Oxidation-Reduction; Pharmaceutical Preparations; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Structure-Activity Relationship; Tetrazoles

2005
Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ.
    Journal of medicinal chemistry, 2011, Jun-23, Volume: 54, Issue:12

    Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biological Availability; Blood Glucose; Crystallography, X-Ray; Drug Partial Agonism; Humans; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Male; Models, Molecular; PPAR gamma; Pyridines; Radioligand Assay; Rats; Rats, Inbred SHR; Stereoisomerism; Structure-Activity Relationship; Transcriptional Activation; Triglycerides

2011